Advancements towards safer adoptive cell therapies: Immatics to present at the WORLD ADOPT Summit (March 7-9, London)
Date/ Time: Wednesday, March 8, 2017/ 12pm – 12.30pm
Yannick Bulliard, Director Product Science, Immatics US Inc.
Session: Innovating Cell Therapy Targeting
Title: XPRESIDENT®-Guided Target Identification and Profiling of On- and Off-Target Toxicity for Safer Adoptive Cell Therapy